Patents by Inventor Poulami Talukder

Poulami Talukder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS
    Publication number: 20240093238
    Abstract: Nanoparticle compositions for delivery of nucleic acids to subjects including carriers comprising sugar functionalized nucleic acid carriers, and therapeutic or immunogenic nucleic acid agents enclosed within the delivery molecules are described. Methods for treating or preventing diseases or conditions in a subject by administering the nanoparticle compositions that provide immune responses and synergistic therapeutic or preventive effects are provided.
    Type: Application
    Filed: November 21, 2023
    Publication date: March 21, 2024
    Applicant: TIBA Biotech LLC
    Inventors: Poulami Talukder, Jasdave Chahal
  • Nanoparticle compositions containing sugar functionalized nucleic acid carriers
    Patent number: 11859201
    Abstract: Nanoparticle compositions for delivery of nucleic acids to subjects including carriers comprising sugar functionalized nucleic acid carriers, and therapeutic or immunogenic nucleic acid agents enclosed within the delivery molecules are described. Methods for treating or preventing diseases or conditions in a subject by administering the nanoparticle compositions that provide immune responses and synergistic therapeutic or preventive effects are provided.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: January 2, 2024
    Assignee: TIBA BIOTECH LLC
    Inventors: Poulami Talukder, Jasdave Chahal
  • NANOPARTICLE COMPOSITION FOR THE DELIVERY OF NUCLEIC ACID AGENTS
    Publication number: 20230310645
    Abstract: The present disclosure relates to nanoparticle compositions for delivery of nucleic acid agents. The nanoparticle composition disclosed includes a carrier containing a dendritic polymer skeleton, a PEG moiety, an amine, and a hydrophobic unit. The size of the PEG moiety may be limited, potentially reducing or avoiding anti-PEG antibody induction.
    Type: Application
    Filed: April 3, 2023
    Publication date: October 5, 2023
    Applicant: Tiba Biotech LLC
    Inventors: Poulami Talukder, Maria Varghese
  • CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY
    Publication number: 20230149562
    Abstract: Nanoparticle compositions for delivery of nucleic acids to subjects including carriers comprising polyester (PE) dendrimers or dendrons, and therapeutic or immunogenic nucleic acid agents enclosed within the PE are described. Methods for treating or preventing diseases or conditions in a subject by administering the nanoparticle compositions that provide immune responses and synergistic therapeutic or preventive effects are provided.
    Type: Application
    Filed: April 2, 2021
    Publication date: May 18, 2023
    Applicant: TIBA Biotech LLC
    Inventors: Poulami TALUKDER, Jasdave CHAHAL, Jin HUANG, Karl RUPING
  • NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS
    Publication number: 20230100837
    Abstract: Nanoparticle compositions for delivery of nucleic acids to subjects including carriers comprising sugar functionalized nucleic acid carriers, and therapeutic or immunogenic nucleic acid agents enclosed within the delivery molecules are described. Methods for treating or preventing diseases or conditions in a subject by administering the nanoparticle compositions that provide immune responses and synergistic therapeutic or preventive effects are provided.
    Type: Application
    Filed: August 11, 2022
    Publication date: March 30, 2023
    Applicant: TIBA Biotech LLC
    Inventors: Poulami Talukder, Jasdave Chahal
  • TRIOXOLANE AGENTS
    Publication number: 20220411396
    Abstract: Disclosed herein, inter alia, are trioxolane compounds and methods of using the same for treatment and detection of diseases.
    Type: Application
    Filed: February 25, 2022
    Publication date: December 29, 2022
    Inventors: Adam Robert Renslo, Brian Richard Blank, Ryan Keith Muir, Michael John Evans, Poulami Talukder
  • NANOPARTICLE COMPOSITIONS FOR EFFICIENT NUCLEIC ACID DELIVERY AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20210330600
    Abstract: Nanoparticle compositions for delivery of nucleic acids to subjects including modified dendrimers comprising cores, one or more of homogeneous or heterogeneous intermediate and terminal layers, and therapeutic or immunogenic nucleic acid agents enclosed within nanop article compositions are described. Methods for treating or preventing diseases or conditions in a subject by administering the nanoparticle compositions that provide immune responses and synergistic therapeutic or preventive effects are provided.
    Type: Application
    Filed: December 19, 2019
    Publication date: October 28, 2021
    Applicant: TIBA BIOTECH LLC
    Inventors: Poulami TALUKDER, Jasdave CHAHAL, Justine McPARTLAN, Omar KHAN, Karl RUPING
  • Trioxolane agents
    Patent number: 11072594
    Abstract: Disclosed herein, inter alia, are trioxolane compounds and methods of using the same for treatment and detection of diseases.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: July 27, 2021
    Assignee: The Regents of the University of California
    Inventors: Adam Robert Renslo, Brian Richard Blank, Ryan Keith Muir, Michael John Evans, Poulami Talukder
  • TRIOXOLANE AGENTS
    Publication number: 20200140406
    Abstract: Disclosed herein, inter alia, are trioxolane compounds and methods of using the same for treatment and detection of diseases.
    Type: Application
    Filed: June 27, 2018
    Publication date: May 7, 2020
    Inventors: Adam Robert Renslo, Brian Richard Blank, Ryan Keith Muir, Michael John Evans, Poulami Talukder
  • Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
    Patent number: 9388163
    Abstract: The present disclosure provides methods for identifying therapeutic agents that are multifunctional radical quenchers. It also provides compounds of formula: and pharmaceutically acceptable salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and/or oxidative stress and/or lipid peroxidation.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: July 12, 2016
    Assignee: Arizona Board of Regents, a Body Corporate of the State of Arizona, Acting for and on Behalf of Arizona State University
    Inventors: Sidney Hecht, Omar Khdour, Sandipan Roy Chowdhury, Poulami Talukder
  • Multifunctional Radical Quenchers For The Treatment Of Mitochondrial Dysfunction
    Publication number: 20150266851
    Abstract: The present disclosure provides methods for identifying therapeutic agents that are multifunctional radical quenchers. It also provides compounds of formula (I), (II), or (II-A): and pharmaceutically acceptable salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and/or oxidative stress and/or lipid peroxidation.
    Type: Application
    Filed: June 5, 2015
    Publication date: September 24, 2015
    Inventors: Sidney Hecht, Omar Khdour, Sandipan Roy Chowdhury, Poulami Talukder
  • Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
    Patent number: 9102626
    Abstract: The present disclosure provides methods for identifying therapeutic agents that are multifunctional radical quenchers. It also provides compounds of formula (I), (II), or (II-A): and pharmaceutically acceptable salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and/or oxidative stress and/or lipid peroxidation.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: August 11, 2015
    Assignee: Arizona Board of Regents, a Body Corporate of the State of Arizona
    Inventors: Sidney Hecht, Omar Khdour, Sandipan Roy Chowdhury, Poulami Talukder
  • Multifunctional Radical Quenchers For The Treatment Of Mitochondrial Dysfunction
    Publication number: 20140038963
    Abstract: The present disclosure provides methods for identifying therapeutic agents that are multifunctional radical quenchers. It also provides compounds of formula (I), (II), or (II-A): and pharmaceutically acceptable salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and/or oxidative stress and/or lipid peroxidation.
    Type: Application
    Filed: April 4, 2012
    Publication date: February 6, 2014
    Inventors: Sidney Hecht, Omar Khdour, Sandipan Roy Chowdhury, Poulami Talukder